PharmD students assess furnishing of HIV medication at local pharmacies

In 2019, California passed State Bill 159 (SB-159), enabling pharmacists to furnish HIV medications directly to patients. Students in the UCSF School of Pharmacy's doctor of pharmacy (PharmD) degree program surveyed pharmacies across the San Francisco Bay Area and found that few were actually taking advantage of this newly-approved role for pharmacists.

The findings from the study were published in the Journal of the American Pharmacists Association (JAPhA) on August 7.

The study was the result of a student group's Discovery Project, which is the capstone research project required during the second year of the new 3-year, year-round PharmD curriculum.  Students Rob Bellman, Sheila Mohebbi, Nikki Nobahar, and Jacqueline Parizher were particularly diligent in carrying out their project under the guidance of School faculty member Dorie Apollonio, PhD, MPP, leading the group to be the first in their cohort to have their research published.

The findings will also be presented at the 2021 American College of Clinical Pharmacology (ACCP) Annual Meeting, which will be held September 13-17, 2021.


An observational survey assessing the extent of PrEP/PEP furnishing in San Francisco Bay Area pharmacies (JAPhA)


Department of Clinical Pharmacy, PharmD Degree Program

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.